Vaccination and infection prevention in inflammatory bowel disease

The current medical therapy used in Crohn’s disease and ulcerative colitis comprises drugs that interfere with immune response and therefore caution is needed for infectious side effects, and where possible, strategies to prevent their occurrence should be undertaken. Last year, international consen...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeire, Severine, Van Assche, Gert, Rutgeerts, Paul
Formato: Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998810/
https://www.ncbi.nlm.nih.gov/pubmed/21170370
http://dx.doi.org/10.3410/M2-80
_version_ 1782193403896791040
author Vermeire, Severine
Van Assche, Gert
Rutgeerts, Paul
author_facet Vermeire, Severine
Van Assche, Gert
Rutgeerts, Paul
author_sort Vermeire, Severine
collection PubMed
description The current medical therapy used in Crohn’s disease and ulcerative colitis comprises drugs that interfere with immune response and therefore caution is needed for infectious side effects, and where possible, strategies to prevent their occurrence should be undertaken. Last year, international consensus guidelines on this topic were published by the European Crohn’s and Colitis Organisation.
format Text
id pubmed-2998810
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Faculty of 1000 Ltd
record_format MEDLINE/PubMed
spelling pubmed-29988102010-12-17 Vaccination and infection prevention in inflammatory bowel disease Vermeire, Severine Van Assche, Gert Rutgeerts, Paul F1000 Med Rep Review Article The current medical therapy used in Crohn’s disease and ulcerative colitis comprises drugs that interfere with immune response and therefore caution is needed for infectious side effects, and where possible, strategies to prevent their occurrence should be undertaken. Last year, international consensus guidelines on this topic were published by the European Crohn’s and Colitis Organisation. Faculty of 1000 Ltd 2010-11-11 /pmc/articles/PMC2998810/ /pubmed/21170370 http://dx.doi.org/10.3410/M2-80 Text en © 2010 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Vermeire, Severine
Van Assche, Gert
Rutgeerts, Paul
Vaccination and infection prevention in inflammatory bowel disease
title Vaccination and infection prevention in inflammatory bowel disease
title_full Vaccination and infection prevention in inflammatory bowel disease
title_fullStr Vaccination and infection prevention in inflammatory bowel disease
title_full_unstemmed Vaccination and infection prevention in inflammatory bowel disease
title_short Vaccination and infection prevention in inflammatory bowel disease
title_sort vaccination and infection prevention in inflammatory bowel disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998810/
https://www.ncbi.nlm.nih.gov/pubmed/21170370
http://dx.doi.org/10.3410/M2-80
work_keys_str_mv AT vermeireseverine vaccinationandinfectionpreventionininflammatoryboweldisease
AT vanasschegert vaccinationandinfectionpreventionininflammatoryboweldisease
AT rutgeertspaul vaccinationandinfectionpreventionininflammatoryboweldisease

Ejemplares similares